Aclaris therapeutics to participate in the jefferies healthcare conference

Wayne, pa., june 01, 2022 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that dr. neal walker, president and ceo of aclaris, will participate in a fireside chat at the jefferies healthcare conference on wednesday, june 8, 2022 at 11:30 a.m. et in new york, new york. management will be available june 8th for 1x1 meetings.
ACRS Ratings Summary
ACRS Quant Ranking